We are live on ! Find out more
VNDA icon

Vanda Pharmaceuticals
VNDA

152 hedge funds and large institutions have $206M invested in Vanda Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 52 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

501% more call options, than puts

Call options by funds: $1.57M | Put options by funds: $261K

25% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 20

3% more funds holding

Funds holding: 148 → 152 (+4)

0.65% more ownership

Funds ownership: 74.8% → 75.45% (+0.65%)

10% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 52

16% less capital invested

Capital invested by funds: $246M → $206M (-$39.7M)

Holders
152
Holders Change
+4
Holders Change %
+2.7%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
47
Reduced
52
Closed
20
Calls
$1.57M
Puts
$261K
Net Calls
+$1.31M
Net Calls Change
+$2.12M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.45M
2
Goldman Sachs
Goldman Sachs
New York
+$2.16M
3
Millennium Management
Millennium Management
New York
+$2.05M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.33M
5
TCM
Tang Capital Management
California
+$1.07M

Top Sellers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
-$1.99M
2
KAM
Krensavage Asset Management
New York
-$1.33M
3
PIM
Profit Investment Management
Maryland
-$1.29M
4
BCM
BML Capital Management
Indiana
-$910K
5
OAC
OMERS Administration Corp
Ontario, Canada
-$788K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
76
Verition Fund Management
Connecticut
$189K +$15.7K +2,927 +8%
Nomura Holdings
77
Nomura Holdings
Japan
$188K +$215K +40,098 New
BGIM
78
Brandywine Global Investment Management
Pennsylvania
$166K +$185K +34,570 New
FRM
79
Fox Run Management
Connecticut
$157K +$179K +33,446 New
MIM
80
MetLife Investment Management
New Jersey
$155K – – –
Mirae Asset Global ETFs Holdings
81
Mirae Asset Global ETFs Holdings
Hong Kong
$146K +$10.2K +1,896 +6%
GCP
82
GSA Capital Partners
United Kingdom
$143K +$163K +30,423 New
CF
83
Corebridge Financial
Texas
$143K -$1.01K -188 -0.6%
VIA
84
Virtus Investment Advisers
Connecticut
$133K – – –
US Bancorp
85
US Bancorp
Minnesota
$128K -$6.13K -1,143 -4%
HSBC Holdings
86
HSBC Holdings
United Kingdom
$124K +$142K +26,465 New
Wells Fargo
87
Wells Fargo
California
$123K +$3.33K +622 +2%
Envestnet Asset Management
88
Envestnet Asset Management
Illinois
$120K +$7.55K +1,409 +6%
DC
89
Diametric Capital
Massachusetts
$117K – – –
Squarepoint
90
Squarepoint
New York
$116K -$291K -54,192 -69%
HKAM
91
Horizon Kinetics Asset Management
New York
$116K -$5.83K -1,088 -4%
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$108K – – –
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$108K -$3.52K -657 -3%
CC
94
Corton Capital
Ontario, Canada
$104K +$118K +22,074 New
VF
95
Virtu Financial
New York
$102K -$233K -43,435 -67%
SG Americas Securities
96
SG Americas Securities
New York
$96K +$51.4K +9,580 +89%
VOYA Investment Management
97
VOYA Investment Management
Georgia
$92.8K +$2.43K +454 +2%
T. Rowe Price Associates
98
T. Rowe Price Associates
Maryland
$89K +$10K +1,865 +11%
IIM
99
INTECH Investment Management
Florida
$84.5K +$96.6K +18,014 New
PCM
100
Prelude Capital Management
New York
$83K +$536 +100 +0.6%
2 3
4
5 6

VNDA Hedge Fund Activity: Q3 2024 in Review

152 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Vanda Pharmaceuticals (VNDA) for Q3 2024, worth a combined $206M — down 16% from $246M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new VNDA positions and 20 closed out — a net gain of 5 holders — while 47 added to existing stakes and 52 trimmed.

The largest buyer was BlackRock, adding an estimated $2.45M. The largest seller was Nuveen, cutting an estimated $1.99M.

  • 152 institutional investors held Vanda Pharmaceuticals (VNDA) as of Q3 2024, up from 148 in Q2 2024.
  • Funds reported $206M of Vanda Pharmaceuticals stock for Q3 2024, down 16% quarter-over-quarter.
  • 25 funds opened new Vanda Pharmaceuticals positions in Q3 2024 and 20 closed out, a net change of +5 holders.
  • The largest Vanda Pharmaceuticals buyer in Q3 2024 was BlackRock, an estimated $2.45M added.
  • The largest Vanda Pharmaceuticals seller in Q3 2024 was Nuveen, an estimated $1.99M sold.

Based on aggregated 13F filings for Q3 2024.